PXMBF (Paxman AB) Other Current Receivables: $0.29 Mil (As of Mar. 2026)


PXMBF Paxman AB PXMBF
80 GF Score
Price $3.50
GF Value $4.48
! 3 Warning Signs
View Full Analysis

What is Paxman AB Other Current Receivables?

Paxman AB PXMBF 80 Other Current Receivables is $0.29 Mil as of Mar. 2026. GuruFocus rates PXMBF with a GF Score™ of 80/100 and a GF Value™ of $4.48. The stock has 3 warning signs investors should review.

Paxman AB's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.29 Mil.

Paxman AB's quarterly Other Current Receivables increased from Sep. 2025 ($0.37 Mil) to Dec. 2025 ($2.50 Mil) but then stayed the same from Dec. 2025 ($2.50 Mil) to Mar. 2026 ($0.29 Mil).

Paxman AB's annual Other Current Receivables increased from Dec. 2023 ($0.84 Mil) to Dec. 2024 ($1.60 Mil) and increased from Dec. 2024 ($1.60 Mil) to Dec. 2025 ($2.50 Mil).

Paxman AB Other Current Receivables Related Terms

Paxman AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Paxman AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paxman AB Other Current Receivables Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only 0.58 1.12 0.84 1.60 2.50

Paxman AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.35 0.37 2.50 0.29
PXMBF
80GF Score
Paxman AB PXMBF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paxman AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.29 Mil mean?
Paxman AB (PXMBF) has a Other Current Receivables of $0.29 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Paxman AB and its competitors.
Is Paxman AB's Other Current Receivables too high?
Paxman AB's current Other Current Receivables is $0.29 Mil. Overall, Paxman AB has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Other Current Receivables compare to ABT and SYK?
Paxman AB's Other Current Receivables of $0.29 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Paxman AB and its competitors. Paxman AB's current Other Current Receivables is $0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Other Current Receivables of $0.29 Mil. The stock's GF Value™ is $4.48, compared to a current price of $3.50 — trading 21.9% below its estimated fair value. The current Other Current Receivables is $0.29 Mil. Paxman AB's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Other Current Receivables is $0.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paxman AB (PXMBF) Overvalued in 2026?

Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued. The current stock price of $3.50 is trading 21.9% below its estimated GF Value™ of $4.48.

Key valuation signals for PXMBF:

  • Other Current Receivables: $0.29 Mil
  • GF Value™: $4.48 vs. price of $3.50 (21.9% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paxman AB Business Description

Other Exchanges PAX:SwedenB0F:Germany
Address Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
80GF Score

Get the complete analysis for PXMBF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price
$4.48
GF Value